Skip to content
  • Wednesday, 15 April 2026
  • 10:17 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Novo Nordisk’s triple agonist delivers up to 19.7% average weight loss in Phase 2 trial
Laboratory Automation & Robotics

Novo Nordisk’s triple agonist delivers up to 19.7% average weight loss in Phase 2 trial

Lana Keisha Mar 18, 2026 0

Novo Nordisk, a global leader in diabetes and obesity care, announced a significant advancement in its weight management pipeline with…

Read More

Posts pagination

1 2
Advanced Computational Framework Unlocks the Potential of Polyheptazine Imide Materials for Large Scale Solar Energy ConversionMars’s Tiny Survivors: Yeast Offer Clues to Extraterrestrial Life’s ResilienceRegeneron Pharmaceuticals and Telix Pharmaceuticals Forge Strategic Alliance to Advance Precision Oncology Through Radiopharmaceutical InnovationPenn Engineering and CHOP Researchers Develop Advanced Bone Marrow on a Chip to Revolutionize Drug Development and Space Medicine
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityLLMOps in 2026: The 10 Tools Every Team Must HaveWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Breakthrough in Male Contraception: Cornell Scientists Identify Nonhormonal Pathway to Reversible Infertility via Meiotic InterruptionThe Quest for Monoclonality: Sartorius Infographic Illuminates Next-Generation Solutions for Cell-Line DevelopmentImmuto Scientific Pioneers AI-Enhanced Mass Spectrometry for Unprecedented Protein Structure ThroughputMental Sharpness and Daily Productivity Gains Quantified in New University of Toronto Study
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Breakthrough in Male Contraception: Cornell Scientists Identify Nonhormonal Pathway to Reversible Infertility via Meiotic Interruption
Dwi Wanna Apr 15, 2026
Biotech & Genetic Research
The Quest for Monoclonality: Sartorius Infographic Illuminates Next-Generation Solutions for Cell-Line Development
Jia Lissa Apr 15, 2026
Laboratory Automation & Robotics
Immuto Scientific Pioneers AI-Enhanced Mass Spectrometry for Unprecedented Protein Structure Throughput
Lana Keisha Apr 15, 2026
Neuroscience & Brain Research
Mental Sharpness and Daily Productivity Gains Quantified in New University of Toronto Study
Rifan Muazin Apr 15, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ